The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 23, 2025
Filed:
Oct. 08, 2020
Applicant:
Oncobix Co., Ltd., Yongin-si, KR;
Inventors:
Sung-Eun Kim, Seoul, KR;
Sunho Lee, Seoul, KR;
Rengasamy Rajesh, Suwon-si, KR;
Yong Hyub Lee, Goyang-si, KR;
Sung Tak Hong, Seoul, KR;
Assignee:
ONCOBIX CO., LTD., Yongin-si, KR;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 413/14 (2006.01); C07D 403/14 (2006.01); C07D 417/14 (2006.01); C07D 487/10 (2006.01); C07D 491/107 (2006.01);
U.S. Cl.
CPC ...
C07D 413/14 (2013.01); C07D 403/14 (2013.01); C07D 417/14 (2013.01); C07D 487/10 (2013.01); C07D 491/107 (2013.01);
Abstract
The present invention provides a novel compound represented by Chemical Formula 1 or a salt thereof and a pharmaceutical composition for treating lung cancer containing same. A pyrimidine derivative compound represented by Chemical Formula 1 effectively inhibits the growth of cancer cells with an ALK mutation and an EGFR mutation, thereby being effectively usable in the treatment of lung cancer.
Kim, Sung-Eun. (2025). Heterocyclic-substituted pyrimidine derivative exhibiting cancer cell growth inhibitory effect, and pharmaceutical composition containing same (U.S. Patent No. 12421221). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12421221
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile